Triple
T9833870
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | diphtheria antitoxin |
E239052
|
entity |
| Predicate | instanceOf |
P0
|
FINISHED |
| Object | serum therapy |
C7497
|
CONCEPT FINISHED |
Disambiguation candidates (1 decision)
The exact options the model was shown at each disambiguation step, with the option it chose highlighted — the evidence behind this triple's disambiguated ids.
CD
Concept disambiguation
gpt-5-mini-2025-08-07
Target class: serum therapy Context triple: [diphtheria antitoxin, instanceOf, serum therapy]
-
A.
biologic therapy
chosen
Biologic therapy is a treatment that uses substances made from living organisms or their derivatives to target specific components of the immune system or disease processes.
-
B.
monoclonal antibody
A monoclonal antibody is a laboratory-produced molecule engineered to bind specifically to a single epitope on an antigen, enabling targeted detection or treatment of diseases.
-
C.
immunosuppressive agent
An immunosuppressive agent is a drug or substance that reduces or inhibits the activity of the immune system to prevent or treat immune-mediated damage, such as in organ transplantation or autoimmune diseases.
-
D.
Ebola vaccine
An Ebola vaccine is a biomedical product designed to stimulate the immune system to provide protection against infection by the Ebola virus.
-
E.
biochemical enhancement serum
A biochemical enhancement serum is a specialized liquid compound designed to alter or augment an organism’s biological functions at the molecular level, typically to improve physical or cognitive performance.
- F. None of above.
Provenance (1 batch)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69ca84e314108190978324a4bdb959f8 |
elicitation | completed |
Created at: March 30, 2026, 8:32 p.m.